Fenacor
is indicated as adjunctive therapy to diet to reduce elevated
low-density lipoprotein cholesterol (LDL-C), total cholesterol
(Total-C), Triglycerides and apolipoprotein B (Apo B), and to
increase high-density lipoprotein cholesterol (HDL-C) in adult
patients with primary hypercholesterolemia or mixed dyslipidemia.
Note : This
product information is intended only for residents of the
India. Taj Pharmaceuticals Limited, medicines
help to treat and prevent a range of conditions—from the
most common to the most
challenging—for people around the world.
Fenacor ®
fenofibrate tablets & Capsules USP 145 mg/ 160 mg & 200 mg
Fenofibrate Capsules (Micronized) USP 67mg /134 mg / 150 mg &
200 mg
Information for Health Care Professionals
*** Please consult local Prescribing
Information for any product before use. This website is an
international information resource for healthcare
professionals with an interest in disease management. This
website is not intended to replace the advice of a
qualified healthcare professional. Above brand is a
trademark of the Taj group of companies (Taj
Pharmaceuticals Limited).
|